Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy.
Nafise GhalandariErik KemperIneke Hubertina CrijnsGertjan WolbinkTheo RispensHieronymus T W SmeeleRadboud Jem DolhainPublished in: Annals of the rheumatic diseases (2021)
Compliance with the EULAR-PtC results in absence or low levels of TNFi in cord blood.
Keyphrases